Syverson Strege & Co’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-14	Closed	-$2.8K	–	83
2023 Q1	$2.8K	Buy	+14	New	+$2.8K	﹤0.01%	426